Limited access to buprenorphine restricts resident physicians treating opioid abusers

(University of South Florida (USF Health)) A University of South Florida Health-led survey of resident physicians in Florida indicates they are interested in treating opioid addiction but face barriers to offering patients treatment using buprenorphine, an FDA-approved medication shown to successfully decrease opioid use, overdose events, and deaths associated with opioids. Many states have reported increased deaths from opioids since the COVID-19 epidemic began, underscoring the need to remove ...